Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

23.52 +0.43 (+1.86%)
Streaming Delayed Price Updated: 10:40 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via GlobeNewswire
Rosen Law Firm Urges Baxter International Inc. (NYSE: BAX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
From Faruqi & Faruqi, LLP
Via Business Wire
Peering Into Baxter International Inc's Recent Short Interest
 
Via Benzinga
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Labaton Keller Sucharow LLP Files Securities Class Action Against Baxter International, Inc. and Certain of Its Executives
From Labaton Keller Sucharow LLP
Via Business Wire
Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Why Baxter (BAX) Stock Is Falling Today
Shares of healthcare company Baxter International (NYSE:BAX) fell 3% in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President... 
Via StockStory
Topics Economy Government World Trade
Forecasting The Future: 6 Analyst Projections For Baxter Intl
 
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
These S&P500 stocks are moving in today's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday. 
Via Chartmill
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)
From Baxter International Inc.
Via Business Wire
Trump Administration Review Targets Medical Supply Chain Vulnerabilities
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign... 
Via Benzinga
Topics Economy Government Supply Chain
Why Baxter (BAX) Stock Is Trading Lower Today
Shares of healthcare company Baxter International (NYSE:BAX) fell 3.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and... 
Via StockStory
Topics World Trade
1 Cash-Producing Stock with Solid Fundamentals and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Reasons to Avoid BAX and 1 Stock to Buy Instead
Baxter has gotten torched over the last six months - since March 2025, its stock price has dropped 32% to $22.86 per share. This was partly driven by its softer quarterly results and might have... 
Via StockStory
Topics Government World Trade
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
From Baxter International Inc.
Via Business Wire
What's Driving the Market Sentiment Around Baxter Intl?
 
Via Benzinga
Unusual volume S&P500 stocks in Tuesday's session
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below. 
Via Chartmill
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon. 
Via Benzinga
Topics Stocks
Baxter, U.S. Physical Therapy, Cogent, HNI, and TD SYNNEX Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Medical Devices & Supplies - Diversified Stocks Q2 In Review: Baxter (NYSE:BAX) Vs Peers
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers. 
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday. 
Via Chartmill
BAX Q2 Deep Dive: Margin Pressure and Product Headwinds Temper Near-Term Outlook
Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter’s revenue... 
Via StockStory
2 Mid-Cap Stocks with Solid Fundamentals and 1 We Brush Off
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
1 S&P 500 Stock to Target This Week and 2 We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Baxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A Rebound
Stifel warned that Baxter’s path to consistent growth and margin expansion may take longer than expected, pointing to a cautious 2026 outlook. 
Via Stocktwits
Topics Death Earnings World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.